UT Regents fund pioneering trauma care research center

November 28, 2022

The University of Texas System Board of Regents on Nov. 17 approved $2.5 million to establish the Trauma Research and Combat Casualty Care Collaborative at UT Health San Antonio in partnership with University Health’s Level 1 Trauma Center at University Hospital and the U.S. Department of Defense. The new trauma care research center will be the first and only one of its kind in the United States, according to UT System.

Master of Science in Speech-Language Pathology program receives accreditation

August 11, 2022

  Four years after welcoming its first cohort of students, the Master of Science in Speech-Language Pathology program has received its five-year accreditation. “This is a five-year milestone we reached, and this is going to turn into another chapter,” said Associate Professor and Department Chair Fang-Ling Lu, PhD, CCC-SLP. “We’re going to keep improving and […]

Speech-language pathology professor instructs master's students

New therapy significantly reduces headache disability, post-traumatic stress after brain injury, study finds

June 27, 2022

  Media contact: Steven Lee, lees22@uthscsa.edu, (210) 450-3823, or Will Sansom, sansom@uthscsa.edu, (210) 567-2579 Produced and contributed by Joel Williams and Julie Collins. SAN ANTONIO (June 27, 2022) – The first therapy to be developed specifically for post-traumatic headache significantly reduced related disability in veterans following a traumatic brain injury (TBI). It also reduced co-occurring symptoms of […]

Photo of stressed soldier

Novel brain injury treatment tested in 1st human subject

June 15, 2022

Drug conceived at UT Health San Antonio was safe, effective in animal studies Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO, TEXAS, AND GROTON, CONN. (Wednesday, June 15, 2022) — An experimental brain injury medication conceived in laboratories at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was tested Tuesday, […]

Neuron concept art

In the race to solve Alzheimer’s disease, scientists find more needles in the haystack

April 20, 2022

Thanks to international collaboration, more genetic variations for Alzheimer’s disease are known today than ever before. The list of gene variants recognized for late-onset Alzheimer’s grew from one in 2009 to 40 in 2022. This month, scientists published a list of 75, some of which are considered as prime drug targets. Drug development is underway.

In the quest for a TBI therapy, astrocytes may be the bull’s-eye

February 9, 2022

Treatment could aim to raise levels of a neuroprotective molecule, studies hint. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Feb. 9, 2022) — Growing evidence suggests that traumatic brain injury (TBI) is an important risk factor for developing Alzheimer’s disease and dementia. But to date, effective therapies aren’t available for preventing or treating TBI-induced […]

Neuron concept art